Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study

- Mehdi Kashani

- Mehdi Karimi

- Alireza Sharifi Rayeni

- Mohammad Ali Azizi Nadian

- Masoud Mortezazadeh

- Amirhossein Parsaei

- Nooshin Abolghasemi

- Niyousha Shirsalimi

- Abbas Mofidi

- Seyyed Taher Seyyed Mahmoudi

2. The Effectiveness of Sovodak in the Treatment of Patients with Chronic Hepatitis C

- Farshad Talebian

- Baran Parhizkar

- Behzad Mohsenpour

- Pezhman Sharifi

- Amirreza Hajati

- Farshad Sheikhesmaeili

3. A rapid review of the epidemiology and combating strategies of hepatitis C virus infection in Ghana

- Marcarious M. Tantuoyir

- Muhammed Camara

- Marjan Sohrabi

- SeyedAhmad SeyedAlinaghi

- Zahra Ahmadinejad

4. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

5. Generic Direct Acting Antiviral Treatment: The First Step Towards Elimination of Hepatitis C in Iran

- Behzad Hajarizadeh

6. Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis

- Mohammad Ehsan Bayatpoor

- Mohammad Hossein Khosravi

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian

7. Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”

- Babak Sayad

- Fatemeh Norooznezhad

- Alireza Farokhi

8. Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes

- Mohamed Darwish Ahmed Abd Alla

- Reham M. Dawood

- Hassan Abd EL-Hafeth Rashed

- Galal Farrag

- Islam Abdelmawla Emran Ammar

- Mohamed Mahmoud Abdel-Halim Mahmoud

- Ghada M. Salum

- Ahmed Mohamed Abdulhamid Altanbouly

- Mai A. El Meguid

- Mostafa K. El Awady

9. An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study

- Maryam Alavi

- Hossein Poustchi

- Shahin Merat

- Soudeh Kaveh-ei

- Afarin Rahimi-Movaghar

- Behrang Shadloo

- Behzad Hajarizadeh

- Jason Grebely

- Gregory J. Dore

- Reza Malekzadeh